LGM
MDGL icon

Logos Global Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Logos Global Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-85,000
Closed -$44.5M – 79
2026
Q1 		$44.5M Buy
+85,000
New +$40.6M 2.22% 13
2025
Q3 		– Sell
-50,000
Closed -$15.1M – 66
2025
Q2 		$15.1M Buy
+50,000
New +$14.9M 1.67% 21
2023
Q2 		– Sell
-50,000
Closed -$12.1M – 57
2023
Q1 		$12.1M Sell
50,000
-10,000
-17% -$2.72M 1.73% 24
2022
Q4 		$17.4M Buy
+60,000
New +$5.87M 2.04% 20
2020
Q1 		– Sell
-27,279
Closed -$2.48M – 49
2019
Q4 		$2.48M Buy
+27,279
New +$2.65M 0.61% 33

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Logos Global Management's MDGL Position: Q2 2026 in Review

Logos Global Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 85,000 shares — an estimated $44.5M sold.

Logos Global Management first reported a position in MDGL in Q4 2019 and held it in 5 quarters. The position peaked at $44.5M in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Logos Global Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Logos Global Management sold 85,000 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $44.5M.
  • Logos Global Management first reported a position in Madrigal Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Logos Global Management's Madrigal Pharmaceuticals position peaked at $44.5M in Q1 2026.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.